From: In vivo validation of the adequacy calculator for continuous renal replacement therapies
Parameter | Value (mean ± SD; range) |
---|---|
Total no. of patients | 30 |
Age (years) | 58 ± 12 |
Weight (kg) | 73.7 ± 15.7 (35–105) |
SAPS II score | 38 ± 12 |
No. of evaluated treatments | 106 |
Examined treatment days | 3.5 ± 1.1 |
Prescribed spKt/V | 1.4 |
Diagnosis | Â |
   Sepsis/septic shock | 8 |
   Bowel perforation | 3 |
   Aortic aneurysm repair | 3 |
   Pneumonia | 5 |
   Hemorrhagic shock | 2 |
   Pancreatitis | 1 |
   Multiple trauma | 5 |
   Cardiogenic shock | 3 |
Urine output at RRT start (ml per 24 h) | 150 ± 70 |
Urea levels at RRT start (mg dl-1) | 124 ± 55 |
Urea levels after 24 h from RRT start (mg dl-1) | 98 ± 50 |
Urea levels at RRT withold | 68 ± 53 |
Creatinine levels at RRT start (mg dl-1) | 2.9 ± 0.9 |
Creatinine levels after 24 h from RRT start (mg dl-1) | 2.4 ± 1.25 |
Creatinine levels at RRT withold | 1.8 ± 0.6 |
No. of patients receiving heparin < 500 U h-1 | 12 |
No. of patients receiving heparin > 500 U h-1 | 11 |
No. of patients receiving no anticoagulation | 7 |